| Prev Close | 66.50 |
| Open | 66.32 |
| Day Low/High | 65.73 / 66.46 |
| 52 Wk Low/High | 51.72 / 82.15 |
| Volume | 6.24M |
| Avg Volume | 7.42M |
CVS Health Corp. (CVS)
66.16
0.34
0.51
NYSE : Retail Trade
| Exchange | NYSE |
| Shares Outstanding | 1.30B |
| Market Cap | 85.07B |
| EPS | -0.60 |
| P/E Ratio | 18.43 |
| Div & Yield | 2.00 (3.08%) |
Latest News
Jim Cramer: Watch for Stocks Reporting 'Not as Bad as Feared' Numbers
When you have an oversold market you've got a true coiled spring that can rally beyond where it might ordinary go on good news.
Jim Cramer: Here's Why the Market's So Feckless and Reactive
So many companies -- like Netflix, Facebook and Johnson & Johnson -- are not trading on earnings per share, but on factors that are nearly impossible to quantify.
With CVS, Bulls Still Have Their Work Cut Out for Them
The company appears to be combating the risk of possible cost-cutting reform with their continued diversification.
CVS Must Be Taking Some of Its Own Medicine: It Appears in Great Shape
Following its Aetna acquisition that closed back in November, CVS is positioning itself for further strength.
CVS Health Continues to Move Higher - New Stop Recommendation
CVS continues to move in the right direction for the bulls.
The Charts of CVS Health Are Coming Out of Rehab
Let's check out the charts.
Real Money Post-Industrial Average Holds Own in Turbulent August
Gains in Amgen, CVS, and others helped offset declines in other stocks, as the RMPIA rose over the last two months to 0.6%, handily beating all the major domestic stock market averages.
CBD-Laced Foods Could Be Technically Illegal, But the FDA Might Soon Change That
Agency has the authority to carve out an exception to existing laws.
Uber Gets an Early Lyft
LYFT's earnings beat appears to be giving hope to Uber investors in advance of its own report later Thursday, but the two rivals have key strengths to watch, such as Lyft's U.S. focus and Uber's move on food delivery.
Jim Cramer: In America, Lower Rates Are Nirvana for the Consumer and Stocks
Lower rates are terrible unless you spend money, buy goods, create businesses, refinance loans and basically exist in America.
China's Yuan Threat, Disney Volatility: Market Recon
The Chinese government has now demonstrated an ability to control the S&P 500, even at the risk of Chinese domestic capital flight.
Real Money Post-Industrial Average Leads Major Indexes So Far for Year
In July, the RMPIA climbed 0.6%, bringing its year-to-date return to just over 21%.
CBD Is Flexing on the Marijuana Industry
Be sure your cannabis investments have the right CBD strategy, as the market for these products takes off.
European Debt Markets, Uninverting Curve, Facebook's Libra, Trading Costco
This matters: Why the sudden 'weakness' across European debt markets?
Jim Cramer: Why Laggards Like Kohl's, Citi and CVS Can Rise Now
I am neutral on this market, and only a cool off of the hottest stocks can justify a further advance.
How 'Window Dressing' Can Hide the Losers
By selling out of big losers prior to the quarter's close, portfolio managers can hide the stocks from clients, but some downtrodden shares could be ripe for bounces next week, so here's my list.
Future Looks Healthy for CVS
CVS and Walgreens Boots Alliance make for good buys.
Real Money Post-Industrial Index Continues to Outperform Major Market Indices
Amid May's market turbulence, the RMPIA was buoyed by the more than 4% rise from Medtronic.
3 Managed Care Providers Are Finally Looking Promising on the Charts
A look at the charts and indicators of three big names in the sector .
Make Big Money: Think Like an Insider
Insider buying by corporate officers should be taken as optimistic visions of the future prospects of their companies and their stock prices.
Jim Cramer: With Biden the Democratic Favorite, These Stocks Are Front-Runners
These managed care stocks can withstand China, politics and a slowdown in the economy.
Real Money Post-Industrial Average Leaves Major Indices in the Dust
RMPIA outperformed once gain during April.
A Review of the Regulatory Hurdles Remaining for the CVS Aetna Acquisition
Aetna's additive effects on CVS's earnings might be front and center, but it isn't fully actualized just yet.
'Medicare for All' Efforts Should Rightfully Weigh on CVS Shareholder Minds
As CVS Health's stock continues to run, management's careful approach should be encouraging for beleaguered investors.
Here Are My Trade Ideas for CVS Stock
CVS Health is still a cash flow machine.
CVS Stock Surges as Aetna Acquisition Comes Into View
CVS is setting up an anticipated new stock trajectory for investors.
